Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID).
Ekaterina PazukhinaMargarita AndreevaEkaterina SpiridonovaPolina BobkovaAnastasia ShikhalevaYasmin El-TaraviMikhail RumyantsevAysylu GamirovaAnastasiia BairashevskaiaPolina PetrovaDina BaimukhambetovaMaria PikuzaElina AbdeevaYulia FilippovaSalima DeunezhewaNikita NekliudovPolina BugaevaNikolay BulanovSergey AvdeevValentina KapustinaAlla GuekhtAudrey DunnGalvinPasquale ComberiatiDiego G PeroniChristian ApfelbacherJon GenuneitLuis Felipe ReyesCaroline L H BrackelVictor FominAndrey A SvistunovPeter TimashevLyudmila MazankovaAlexandra MiroshinaElmira SamitovaSvetlana BorzakovaElena BondarenkoAnatoliy A KorsunskiyGail CarsonLouise SigfridJanet T ScottMatthew GreenhawtDanilo BuonsensoMalcolm G SempleJohn O WarnerPiero OlliaroDale M NeedhamPetr GlybochkoDenis ButnaruIsmail M OsmanovDaniel Munblitnull nullPublished in: BMC medicine (2022)
Although prevalence of PCC declined one year after discharge, one in three adults and one in ten children experienced ongoing sequelae. In adults, females and persons with pre-existing hypertension, and in children, persons with neurological comorbidities or allergic respiratory diseases are at higher risk of PCC.